Procalcitonin as a marker of Gram-negative bloodstream infections in hematological patients with febrile neutropenia

References

• Tang Y, Cheng Q, Yang Q, et al. Prognostic factors and scoring model of hematological malignancies patients with bloodstream infections. Infection. 2018;46:513–521.
   PubMed Web of Science ®Google Scholar
• Tofas P, Skiada A, Angelopoulou M, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: analysis of 50 cases. Int J Antimicrob Agents. 2016;47:335–339.
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011;52:e56–e93.
   PubMed Web of Science ®Google Scholar
• Penack O, Becker C, Buchheidt D, et al. Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). Ann Hematol. 2014;93:1083–1095.
   PubMed Web of Science ®Google Scholar
• Peters RP, van Agtmael MA, Danner SA, et al. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis. 2004;4:751–760.
   PubMed Web of Science ®Google Scholar
• Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000;49 Suppl 1:S57–S61.
   PubMed Web of Science ®Google Scholar
• Henriquez-Camacho C, Losa J. Biomarkers for sepsis. Biomed Res Int. 2014;2014:1.
   Google Scholar
• Leli C, Ferranti M, Moretti A, et al. Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections. Dis Markers. 2015;2015:1.
   Web of Science ®Google Scholar
• Oussalah A, Ferrand J, Filhine-Tresarrieu P, et al. Diagnostic accuracy of procalcitonin for predicting blood culture results in patients with suspected bloodstream infection: an observational study of 35,343 consecutive patients (A STROBE-Compliant Article). Medicine (Baltimore). 2015;94:e1774.
   PubMed Web of Science ®Google Scholar
• Yan ST, Sun LC, Jia HB, et al. Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria. Am J Emerg Med. 2017;35:579–583.
   PubMed Web of Science ®Google Scholar
• Murri R, Mastrorosa I, Taccari F, et al. Procalcitonin is useful in driving the choice of early antibiotic treatment in patients with bloodstream infections. Eur Rev Med Pharmacol Sci. 2018;22:3130–3137.
   PubMed Web of Science ®Google Scholar
• Bruno B, Busca A, Vallero S, et al. Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patients. Expert Rev Hematol. 2017;10:543–550.
   PubMed Web of Science ®Google Scholar
• Engel A, Steinbach G, Kern P, et al. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis. 1999;31:185–189.
   PubMed Web of Science ®Google Scholar
• Prat C, Sancho JM, Dominguez J, et al. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leuk Lymphoma. 2008;49:1752–1761.
   PubMed Web of Science ®Google Scholar
• Sarmati L, Beltrame A, Dori L, et al. Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis. Am J Hematol. 2010;85:380–383.
   PubMed Web of Science ®Google Scholar
• Koivula I, Hamalainen S, Jantunen E, et al. Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia. Scand J Infect Dis. 2011;43:471–478.
   PubMed Web of Science ®Google Scholar
• von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis. 2004;23:539–544.
   PubMed Web of Science ®Google Scholar
• Trimboli P, Seregni E, Treglia G, et al. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review. Endocr Relat Cancer. 2015;22:R157–R164.
   PubMed Web of Science ®Google Scholar
• Patout M, Salaun M, Brunel V, et al. Diagnostic and prognostic value of serum procalcitonin concentrations in primary lung cancers. Clin Biochem. 2014;47:263–267.
   PubMed Web of Science ®Google Scholar
• Serio I, Arnaud L, Mathian A, et al. Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review. Clin Rheumatol. 2014;33:1209–1215.
   PubMed Web of Science ®Google Scholar
• Liu W, Sigdel KR, Wang Y, et al. High level serum procalcitonin associated gouty arthritis susceptibility: from a southern chinese han population. PLoS One. 2015;10:e0132855.
   PubMedGoogle Scholar
• Dias BH, Rozario AP, Olakkengil SA, et al. Procalcitonin strip test as an independent predictor in acute pancreatitis. Indian J Surg. 2015;77:1012–1017.
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Beekmann SE, Chapin KC, et al. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol. 2003;41:3655–3660.
   PubMed Web of Science ®Google Scholar
• Opota O, Croxatto A, Prod'hom G, et al. Blood culture-based diagnosis of bacteraemia: state of the art. Clin Microbiol Infect. 2015;21:313–322.
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–281.
   PubMed Web of Science ®Google Scholar
• Sakr Y, Sponholz C, Tuche F, et al. The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection. 2008;36:396–407.
   PubMed Web of Science ®Google Scholar
• Oberhoffer M, Stonans I, Russwurm S, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med. 1999;134:49–55.
   PubMed Web of Science ®Google Scholar
• Elson G, Dunn-Siegrist I, Daubeuf B, et al. Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood. 2007;109:1574–1583.
   PubMed Web of Science ®Google Scholar
• Kumar S, Ingle H, Prasad DV, et al. Recognition of bacterial infection by innate immune sensors. Crit Rev Microbiol. 2013;39:229–246.
   PubMed Web of Science ®Google Scholar
• Muller B, White JC, Nylen ES, et al. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001;86:396–404.
   PubMed Web of Science ®Google Scholar
• Christofilopoulou S, Charvalos E, Petrikkos G. Could procalcitonin be a predictive biological marker in systemic fungal infections? Study of 14 cases. Eur J Intern Med. 2002;13:493–495.
   PubMedGoogle Scholar
• Ortega M, Rovira M, Filella X, et al. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation. Br J Haematol. 2004;126:372–376.
   PubMed Web of Science ®Google Scholar
• Roques M, Chretien ML, Favennec C, et al. Evolution of procalcitonin, C-reactive protein and fibrinogen levels in neutropenic leukaemia patients with invasive pulmonary aspergillosis or mucormycosis. Mycoses. 2016;59:383–390.
   PubMed Web of Science ®Google Scholar
• Gudiol C, Tubau F, Calatayud L, et al. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother. 2011;66:657–663.
   PubMed Web of Science ®Google Scholar
• Marin M, Gudiol C, Ardanuy C, et al. Factors influencing mortality in neutropenic patients with haematologic malignancies or solid tumours with bloodstream infection. Clin Microbiol Infect. 2015;21:583–590.
   PubMed Web of Science ®Google Scholar
• Kim S, Jo S, Lee JB, et al. Incidence of bacteremia and antimicrobial resistance, and associated factors among patients transferred from long-term care hospital. Am J Emerg Med. [cited 2018 Nov 7]. DOI:10.1016/j.ajem.2018.11.013
   Web of Science ®Google Scholar
• Roux D, Danilchanka O, Guillard T, et al. Fitness cost of antibiotic susceptibility during bacterial infection. Sci Transl Med. 2015;7:297ra114.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 2011;9:107.
   PubMed Web of Science ®Google Scholar